Siegfried Holding AG Siegfried Holding AG

Siegfried Holding AG

SFZN

Rang in Aktien #4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Aktienkurs
$88.34
Marktkapitalisierung
$3.87B
Veränderung (1 Tag)
1.68%
Veränderung (1 Jahr)
-12.97%
Land
CH
Handel Siegfried Holding AG (SFZN)

Kategorie

Healthcare
Aktien-Split-Historie für Siegfried Holding AG (SFZN)
Die Aktie Siegfried Holding AG (Symbol: SFZN) durchlief insgesamt 3 Aktiensplits.
Der letzte Aktiensplit fand am Apr 28, 2025 statt.
Eine SFZN-Aktie, die vor dem Jun 23, 1994 gekauft wurde, entspricht heute 200 SFZN-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2025-04-28 10:1 x10 x200
2002-08-06 10:1 x10 x20
1994-06-23 2:1 x2 x2
Aktiensplits ähnlicher Unternehmen oder Wettbewerber